MediXall (MDXL) Gross Margin (2022 - 2024)
MediXall's Gross Margin history spans 3 years, with the latest figure at 57.39% for Q3 2024.
- For Q3 2024, Gross Margin rose 5369.0% year-over-year to 57.39%; the TTM value through Sep 2024 reached 57.29%, up 3728.0%, while the annual FY2023 figure was 23.56%, 7644.0% down from the prior year.
- Gross Margin reached 57.39% in Q3 2024 per MDXL's latest filing, down from 72.39% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q1 2022 to a low of 14.81% in Q1 2023.
- Average Gross Margin over 3 years is 61.36%, with a median of 57.39% recorded in 2024.
- Peak YoY movement for Gross Margin: crashed -11481bps in 2023, then skyrocketed 7214bps in 2024.
- A 3-year view of Gross Margin shows it stood at 100.0% in 2022, then plummeted by -51bps to 48.77% in 2023, then grew by 18bps to 57.39% in 2024.
- Per Business Quant, the three most recent readings for MDXL's Gross Margin are 57.39% (Q3 2024), 72.39% (Q2 2024), and 57.33% (Q1 2024).